Red bayberry extract inhibits growth and virulence gene expression of the human pathogen Vibrio cholerae

1. Jones RN, Huynh HK, Biedenbach DJ et al. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J Antimicrob Chemother 2004; 54: 144–54. 2. Hakenbeck R, Konig A, Kern I et al. Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level b-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J Bacteriol 1998; 180: 1831–40. 3. Sanbongi Y, Ida T, Ishikawa M et al. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob Agents Chemother 2004; 48: 2244–50. 4. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically— Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006. 5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2006. 6. Davies TA, Shang W, Bush K. Activities of ceftobiprole and other b-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x. Antimicrob Agents Chemother 2006; 50: 2530–2.